Arm Holdings plc IPO Preview: Licensing Scale Meets China Risk
Arm Holdings plc is expected to list on the NYSE on 2026-07-30, but the price range has not been disclosed. The company’s business is built on licensing CPU architecture and collecting royalties, with a huge ecosystem behind it. Watch whether investors focus on its 97.5% gross margin profile or the heavy customer concentration and China exposure.
Arm Holdings plc is expected to list on the NYSE on 2026-07-30, but the price range has not been disclosed. The company’s business is built on licensing CPU architecture and collecting royalties, with a huge ecosystem behind it. Watch whether investors focus on its 97.5% gross margin profile or the heavy customer concentration and China exposure.
Quick Facts
Expected listing date: July 30, 2026
Exchange: NYSE
Proposed symbol: ARMS
Status: Expected
Company Overview
Arm Holdings plc is a semiconductor IP company, not a chip manufacturer. Its core business is licensing CPU architecture and related technology, then collecting license fees and royalties from customers that ship chips using Arm designs. Arm says its technology is deployed in more than 350 billion chips and used by over 99% of smartphones, which gives it one of the broadest footprints in the semiconductor stack.
The company was founded in November 1990 as Advanced RISC Machines Ltd. and is headquartered in Cambridge, UK, with a US headquarters in San Jose, California. Its markets span cloud and data center AI, edge AI, mobile, automotive, networking, storage, and embedded/IoT applications. That puts Arm in the middle of a long-term compute shift: more AI workloads, more custom silicon, and more demand for efficient architectures. The competitive backdrop is not a simple head-to-head chip battle; it is a fight between ecosystems, alternative CPU architectures, and customers deciding whether to license, customize, or design around Arm technology.
Why They're Going Public
Arm’s IPO was structured as a secondary offering by SoftBank, so Arm itself did not receive proceeds from the sale of the ADSs. The prospectus says plainly that the company is not selling any ADSs in the offering and will not receive any proceeds from the selling shareholder’s sale.
That means the public listing is less about funding an expansion plan and more about liquidity, market visibility, and creating a public currency around a business that already sits at the center of the semiconductor ecosystem. The listing also gives investors a direct way to own a high-margin IP model tied to AI, mobile, and custom silicon demand.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Arm’s revenue trajectory has been strong. Fiscal 2023 revenue was about $2.68 billion, with gross margin of 96% and net income from continuing operations of $524 million. Fiscal 2024 total revenue rose to $3.233 billion from $2.679 billion, which is roughly 20.7% year-over-year growth. By fiscal 2025, group revenue reached $4.007 billion, up from $3.233 billion the prior year.
The latest figure provided is fiscal 2026 total revenue of $4.920 billion, with external customer revenue of $3.421 billion and related-party revenue of $1.499 billion. Gross profit was $4.799 billion, implying a gross margin of about 97.5%. Arm also reported $1.551 billion in cash and cash equivalents and $850 million in short-term investments as of December 31, 2023. The financial profile is unusually strong on margin, but the revenue mix still depends heavily on a concentrated customer base and recurring royalty flows.
Risk Factors
The biggest risk is customer concentration. In fiscal 2024, Arm’s top five customers accounted for about 54% of revenue, and Arm China alone represented about 21%. That kind of concentration can make quarterly results lumpy and gives a small number of counterparties outsized influence over the business.
Geopolitics is another major issue. The prospectus warns that U.S. and PRC trade and national security policies, tariffs, restricted lists, and export controls could limit Arm’s business directly or through Arm China. Arm also flags revenue volatility, since licensing and royalty revenue can swing significantly between periods, and it notes that customers may choose to license Arm architecture and build their own processors instead of buying Arm processor products. The company’s competitive edge depends on continued R&D investment, so underfunding innovation would also be a risk. The 180-day lock-up adds a near-term overhang once it expires, especially if the float is tight.
Comparable Public Companies
Arm’s closest public comps are imperfect because it is an IP licensor rather than a chip designer, but the most relevant names are Synopsys (SNPS), Cadence Design Systems (CDNS), Qualcomm (QCOM), NVIDIA (NVDA), and AMD (AMD). Synopsys and Cadence are the cleanest software/IP analogs because they monetize semiconductor design infrastructure and intellectual property. Qualcomm is useful because it combines licensing with chip design, while NVIDIA and AMD help frame how investors value compute exposure tied to AI and advanced silicon.
Relative to those peers, Arm stands out for its margin profile and ecosystem reach, but it also has a more concentrated revenue base and more direct China exposure than many software-like peers. The comp set has been mixed over the last 6 to 12 months: Synopsys has been mixed to down, Cadence has been resilient, Qualcomm has been range-bound to modestly up, NVIDIA has been strongly up, and AMD has been up but volatile. Valuation across the group is generally discussed in P/E or EV-sales terms, with Cadence and NVIDIA typically carrying premium multiples and the broader sector trading unevenly rather than in a single hot tape.
Verdict
This is a high-quality business model with a rare combination of scale, margin, and strategic relevance. What shareholders should watch as it prices is whether the market is willing to pay up for a company with 96% to 97.5% gross margins, revenue above $4.9 billion, and a dominant ecosystem, despite the fact that roughly 54% of fiscal 2024 revenue came from the top five customers and Arm China was about 21% of revenue.
The timing angle matters because Arm sits right in the middle of the AI and custom-silicon narrative, which keeps the sector in focus even when broader IPO conditions are uneven. The company already has public-market history, but the setup still feels like a premium technology story rather than a classic capital-raise IPO: the question is not whether Arm has scale, but how much investors will pay for that scale given concentration, China risk, and the fact that the offering is a secondary sale with no proceeds to the company.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
